Chronic idiopathic slow transit constipation: Pathophysiology and management

Colorectal Disease

Volumn 5, Issue 4, 2003, Pages 288-296

  El Salhy, Magdy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autonomic nervous system; Cholecystokinin; Diagnosis; Enteric nervous system; Interstitial cells of cajal; Motilin; Peptide YY; Serotonin; Treatment

Indexed keywords

BISACODYL; COLCHICINE; ENEMA; ERYTHROMYCIN; LAXATIVE; MACROGOL; MAGNESIUM HYDROXIDE; MISOPROSTOL; PRUCALOPRIDE; TEGASEROD;

CHILDBIRTH; COLON MOTILITY; COLON RESECTION; CONSTIPATION; DIETARY FIBER; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE INNERVATION; INTESTINE TRANSIT TIME; MEDLINE; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PELVIS SURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

AUTONOMIC NERVOUS SYSTEM; CHRONIC DISEASE; CONSTIPATION; GASTROINTESTINAL TRANSIT; HUMANS; NEUROSECRETORY SYSTEMS; PEPTIDE YY; SUBSTANCE P;

EID: 0037964619     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00498.x     Document Type: Review

References (110)

1. Sonnenberg A, Koch TR. Physician visits in the United States for constipation. Dig Dis Sci 1989; 34: 606-11.
2. Johansen JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiological study. Gastroenterology 1990; 98: 380-6.
3. Whitehead WE, Chaussade S, Corazziari E, Kumar D. Report of international workshop on management of constipation. Gastroenterol Int 1991; 4: 99-113.
4. El-Salhy M. (2003) Aging and the neuroendocrine system of the gut. In: Neuroimmune Biology (eds Bercizel I and Szentivaayi A) Vol. 9: The neuroendocrine network in aging. (eds. Straub RH and Mocchegiani E). Elsevier Science, Dublin. in press.
5. Candelli M, Nista EC, Zocco MA, Gasbarrini A. Idiopathic chronic constipation. Pathophysiology, diagnosis and treatment. Hepato-Gastroenterology 2001; 48: 1050-7.
6. Wald A. Constipation. Med Clin North Am 2000; 84: 1231-46.
7. Bharucha AE, Philips SF. Slow-transit constipation. Curr Treat Options Gastroenterol 2001; 4: 309-15.
8. Wald A. Slow transit constipation. Curr Treat Options Gastroenterol 2002; 5: 279-83.
9. Mollen RM, Hopman WP, Kuijpers HH, Jansen JB. Abnormlites of upper gut motility in patients with slow-tarnsit constipation. Eur J Gastroenterol Hepatol 1999; 11: 701-8.
10. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? The Lancet 2002; 360: 555-64.
11. Spiller RC. Upper gut dysmotility in slow-transit constipation: is it evidence for a pan-enteric-neurological deficit in severe slow transit constipation. Eur J Gastroenterol Hepatol 1999; 11: 693-6.
12. Chaussade S, Khyari A, Roche H et al. Determination of total and segmental colonic transit in constipated patients. Results in 91 Patients with a new simplified method. Dig Dis Sci 1989; 34: 1168-72.
13. Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol 1995; 90: 1471-5.
14. Lemieus Mc, Kamm MA. Prevalence of genito-urinary symptoms in patients with disordered defecation. Eur J Gastroenterol Hepatol 1994; 6: 719-22.
15. Mollen RMHG, Claassen ATPM, Kuijpers JHC. The evalution and treatment of functional constipation. Scand J Gastroenterol 1997; 32 (Suppl. 223): 8-17.
16. Hinton JM, Lennard-Jones JE. Constipation definition and classification. Postgrad Med J 1968; 44: 1-22.
17. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radioopique markers. Gut 1969; 10: 842-7.
18. Martelli H, Devroede G, Arhan P, Duguay C. Mechanisms of idiopathic constipation: outlet obstruction. Gastroenterology 1978; 75: 623-31.
19. Arhan P, Devroede G, Jehanin G et al. Segmental colonic transit time. Dis Colon Rectum 1981; 24: 625-629.
20. Metcalf A, Philips S, Ziensmeister A et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 40-7.
21. Metcalf A. Transit time. In: Practicle Guide to Anorectal Testing. (ed. Smith LE ), pp. 17-22. Academic Press, New York.
22. Bouchoucha M, Devroede G, Arhan P et al. What is the meaning of colorectal transit time measurement? Dis Colon Rectum 1992; 35: 773-82.
23. Abrahamsson H, Antov S, Bosaeus I. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal X-ray in healthy subjects and constipated patients. Scand J Gastroentreol 1988; 23 (Suppl.): 72-80.
24. Fortherby KJ, Hunter JP. Idiopathic slow transit constipation: whole gut transit times, measured by a new simplified method, are not shortened by opoid antagonist. Aliment Pharmacol Therap 1987; 1: 331-8.
25. Krevesky B, Maurer AH, Fischer RS. Patterns of colonic transit in chronic idiopathic constipation. Am J Gastroenterol 1989; 84: 127-32.
26. Stubbs JB, Valenzuela GA, Stubbs C et al. A non-invasive scintigraphic assessment of the colonic transit of nondigestible solids in man. J Nucl Med 1991; 32: 1375-81.
27. Proano M, Camlleri M, Philips SF, Brown MI, Thomforde M. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol 1990; 21: 856-62.
28. Stivland T, Camilleri M, Vassalo M, Proano M et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991; 101: 107-15.
29. Mclean RG, Smart RC, Gaston-Parry D et al. Colonic transit scintigraphy in health and constipation using oral iodine-131 cellulose. L Nucl Med 1990; 31: 985-9.
30. Basile M, Neri M, Carriero A et al. Measurement of segmental transit through the gut in man: a novel approach by the biomagnetic method. Dig Dis Sci 1992; 37: 1537-43.
31. Nam YS, Pikarsky AJ, Wexnere SD et al. Reproducibility of colonic transit study in patients with chronic constipation. Dis Colon Rectum 2001; 44: 82-92.
32. van der Sjip JRM, Kamm MA, Nightingale JMD et al. Radioisotope determination of regional colonic transit in severe constipation: comparison with radioopaque markers. Gut 1993; 34: 402-8.
33. Bharucha AE, Philips SF. Slow transit constipation. Gastroenterol Clin North Am 2001; 30: 77-95.
34. Raethjen J, Pilot MA, Knowles C, Warner G, Anand P, Williams N. Selective autonomic and sensory deficits in slow transit constipation. J Auton Nerv Syst 1997; 66: 46-52.
35. Knowels CH, Scott SM, Lunniss PJ. Slow transit constipation: a disorder of pelvic autonomic nerves? Dig Dis Sci 2001; 46: 389-401.
36. Roe AM, Bartolo DC, Mortensen NJ. Slow transit constipation. Comparsion between patients with or without previous hysterectomy. Dig Dis Sci 1988; 33: 1159-63.
37. Scott SM, Knowels CH, Newell M, Garvie N, Williams NS, Lunniss PJ. Scintigraphic assessment of colonic transit in women with slow-transit constipation arising de novo and following pelvic surgery or childbirth. Br J Surg 2001; 88: 405-11.
38. Giaroni C, De Ponti F, Cosentino M, Lecchini S, Frigo G. Plasticity in the enteric nervous system. Gastroenterology 1999; 117: 1439-58.
39. Allescher HD. (1991) Postulated physiological and pathophysiological roles on motility. In: Neuropeptides Function in Gastrointestinal Tract. (ed. Daniel EE), pp. 309-400. CRC Press, Boca Raton.
40. El-Salhy M. The possible role the gut neuroendocrine system in diabetes gastroenteropathy. Histol Histopathol 2002; 17: 1153-61.
41. Huizinga JD, Thunderberg L, Kluppel M et al. W/kit gene required for interstitial cells of Cajal and intestinal pacemaker activity. Nature 1995; 373: 347-9.
42. Ward SN, Burns AJ, Torihashi S, Sanders KM. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rythmicity in murine intestine. J Physiol 1994; 480: 91-7.
43. Krishnamurthy S, Scuffler M, Rohrmann CA, Pope CE II. Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 1985; 88: 26-34.
44. Schouten WR, ten Kate FJ, dc Graaf EJ, Gilbert EC, Simons JL, Klük P. Viceral neuropathy in slow-transit constipation. An immunohistochemical investigation with monoclonal antibodies against neurofilament. Dis Colon Rectum 1993; 36: 1112-7.
45. Wedel T, Roblick UJ, Ott V et al. Oligoneuronal hypoganglionosis in patients with idiopathic slow-transit constipation. Dis Colon Rectum 2002; 45: 54-62.
46. Park HJ, Kamm MA, Abbasi AM, Talbot IC. Immunohistochemical study of the colonic muscle innervation in idiopathic chronic constipation. Dis Colon Rectum 1995; 38: 509-13.
47. Stoss F, Meier-Ruge W. Experience with neuronal intestinal dysplasia (NID) in adults. Eur J Pediatr Surg 1994; 4: 298-302.
48. Voderholzer WA, Wiebecke B, Gerum M, Muller-Lissner SA. Dysplasia of the submucous nerve plexus in slow-transit constipation of adults. Eur J Gastroenterol Hepatol 2000; 12: 755-9.
49. He CL, Bugart L, Wang L et al. Decreased interstitial cell of Cajal Volume in patients with slow-transit constipation. Gastroenterology 2000; 118: 14-21.
50. El-Salhy M. Norrgård Ö, Spinnell S. Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol 1999; 34: 1007-11.
51. Penning C, Delemare JB, Beemelman WA, Biemond I, Lamers CB, Masclee AA. Proximal and distal hormone secretion in slow transit constipation. Eur J Clin Invest 2000; 30: 709-14.
52. Sjölund K, Fasth S, Ekman R et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil 1997; 9: 143-50.
53. Paracchi M, Basllisco G, Tagliabue R et al. Postprandial gut peptide plasma levels in women with idiopathic slow-transit constipation. Scand J Gastroenterol 1999; 34: 25-8.
54. Mollen RM, Hopman WP, Kuijper HH, Jansen JB. Plasma cholecystokinin, plasma peptide YY and gallbladder motility in patients with slow transit constipation: effect of intestinal stimulation. Digestion 2000; 62: 185-93.
55. Lincoln J, Crowe B, Kamm MA, Burnstock G, Lennard-Jones JE. Serotonin and 5-hydroxyindolacetic acid increase in sigmoid colon in severe idiopathic constipation. Gastroenterology 1990; 98: 1219-25.
56. Milner P, Crowe R, Kamm MA, Lennard-Jones JE, Burnstock G. Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology 1990; 99: 666-75.
57. Porter AJ, Wattchow DA, Hunter A, Costa M. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int J Colorectal Dis 1998; 13: 208-16.
58. Tzavella K, Rieeeepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE, Muller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 1996; 8: 1207-11.
59. Koch TP, Carney JA, Go L, Go VLW. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterolgy 1988; 94: 300-10.
60. Imaji R, Kubota Y, Hengel P, Hutson JM, Chow CW. Rectal mucosal biopsy compared with laparoscopic seromuscular biopsy in the diagnosis of intestinal neuronal dysplasia in children with slow-transit constipation. J Pediatr Surg 2000; 35: 1724-7.
61. Cortesini C, Cianchi F, Infantino A, Lise M. Nitric oxide synthesis and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci 1995; 40: 2450-5.
62. Dolk A, Broden G. Holström B, Johansson C, Schultzberg M. Slow transit chronic constipation (Arbuthnot Lane's disease). An immunohistochemical study of neuropeptide-containing nerves in resected specimens from the large bowel. Int J Colorectal Dis 1990; 5: 181-7.
63. Tomita R, Fujisaki S, Ikeda T, Fukuzawa M. Role of nitric oxide in the colon of patients with slow-transit constipation. Dis Colon Rectum 2002; 45: 593-600.
64. Bult H, Boeckxstaens GE, Pelckmans PA. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 1990; 345: 346-7.
65. Sjölund K, Ekman R, Akre F, Linder P. Motilin in chronic idiopathic constipation. Scand J Gastroenterol 1986; 21: 914-8.
66. Preston DM, Adrian TE, Christofides ND, Lennard-Jones JE, Bloom SR. positive correlation between symptoms and circulating motilin, pancreatic poly peptide and gastrin in functional bowel disorders. Gut 1985; 26: 1059-64.
67. El-Salhy M, Norrgård Ö. Colonic neuroendocrine peptide levels in patients with chronic idiopathic slow transit constipation. Upsala J Med Sci 1998; 103: 223-30.
68. Slater BJ, Varma SJ, Gillespie JI. Abnormalities in the contractile properties of colonic smooth muscle in idiopathic slow transit constipation. Br J Surg 1997; 84: 181-4.
69. Martin JE, Smith VV, Domizio P. (1999) Myopathies of gastrointestinal tract. In: Recent Advances in Histopathology, Vol. 18. (eds. Lowe J and Underwood JC), pp. 43-62. Churchill Livingstone, Edinburgh.
70. Knowles CH, Nikols CD, Scott SM et al. Smooth muscle inclusion bodies in slow transit constipation. J Pathol 2001; 193: 390-7.
71. Tucker DM, Sandstead HH, Logan GM et al. Dietary fiber and personality factors as determinants of stool output. Gastroenterology 1981; 81: 879-83.
72. Read NW. (1993) Dietary fiber and the gut: action in gastrointestinal disorders. In: Gastrointestinal Disease, 5th edn. (eds. Sleisenger MH and Fordtran SJ), pp. 2097-108. W.B. Saunders, Philadelphia.
73. Wald A, Hinds JP, Caruana BJ. Psychological and physiological characteristics of patients with idiopathic constipation. Gastroenterology 1989; 97: 932-7.
74. Pretson DM, Pfeiffer JM, Lennard-Jones JE. Psychiatric assessment of patients with severe constipation. Gut 1984; 25: A582.
75. Chattat B, Bazzochi G, Balloni M et al. Illness behavior, affective disturbance and intestinal transit time in idiopathic constipation. J Psychosom Res 1997; 42: 95-100.
76. Velio P, Bassotti G. Chronic idiopathic constipation pathophysiology and treatment. Clin Gastroeenterol 1996; 22: 190-6.
77. Peters T, Matthijs G, Depoortere I et al. Erythromycin is a motilin receptor agonist. Am J Physiol 1989; 257: 470-4.
78. Bassotti G, Chiarioni G, Vantini I, Morelli A, Whitehead WE. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. Z Gastroenterol 1998; 36: 209-13.
79. Spiller R. Sertonergic modulating drugs for functional gastrointestinal diseases. Br J Clin Pharmacol 2002; 54: 11-20.
80. Poen AC, Felt-Bersma RJ, Van Dongen PA, Meuwissen SG. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers. Aliment Pharmacol Ther 1999; 13: 1493-7.
81. 4 agonist, purcalopride, in healthy humans. Gut 1999; 44: 682-6.
82. Emmanuel AV, Roy AJ, Nicholls TJ, Kamm MA. Prucalopride, a systemic enterokinetic, for the treatment of constipation. Aliment Pharmacol Ther 2002; 16: 1347-56.
83. 4 receptor partial agonist tegaserode (HTF919) accelerates upper and lower gastrointestinal (GI) transit. Gastroenterology 2000; 118: A845.
84. Arbuthnot Lane W. The results of operative treatment of chronic constipatin. Br Med J 1908; I: 26-30.
85. Arbuthnot Lane W. Chronic intestinal stasis. Br Med J 1909; I: 408-11.
86. Knowles CH, Scott M, Lunniss PJ. Outcome of coloectomy for slow transit constipation. Ann Surg 1999; 230: 627-38.
87. Lubowski DZ, Chen FC, Kennedy MI, King DW. Results of coloectomy for severe slow transit constipation. Dis Colon Rectum 1996; 39: 23-9.
88. Mollen RM, Hopman WP, Oyen WJ, Kuijpers HH, Edelbrock MA, Jansen JB. Effect of subtotal colectomy on gastric emptying of a solid meal in slow transit constipation. Dis Colon Rectum 2001; 44: 1189-95.
89. Mollen RM, Kuijpers HC, Claasen AT. Coloectomy for slow transit constipation: preoperative functional evaluation is important but not a guarantee for a successful outcome. Dis Colon Rectum 2001; 44: 577-80.
90. Sarli L, Costi D, Roncoroni L. Pilot study of subtotal coloectomy with antiperistaltic caecoproectostomy for the treatment of chronic slow-transit constipation. Dis Colon Rectum 2001; 44: 1514-20.
91. Sarli L, Iusco D, Violi V, Roncoroni L. Subtotal colectomy with antiperistaltic caecorectal anastomosis. Tech Coloproctol 2002; 6: 23-6.
92. Preston DM, Hawley PR, Lennard-Jones JE, Todd IP. Results of colectomy for severe idiopathic constipation in women (Arbuthnot Lane's Disease). Br J Surg 1984; 71: 547-52.
93. de Graaf EJ, Gilberts EC, Schouten WR. Role of segmental colonic transit time studies to select patients with slow transit constipation for partial left-sided or subtotal colectomy. Br J Surg 1996; 83: 648-51.
94. You TY, Wang TY, Changchien CR et al. Segmental colectomy in the management of colonic inertia. Am Surg 1998; 64: 775-7.
95. Gray EJ, Marteinsson TH. Dolichocolon: indications for operations. Am Surg 1971; 37: 509-11.
96. Levitan R, Fordtran SJ, Burrows BA, Ingelfinger FJ. Water and salt absorption in human colon. J Clin Invest 1962; 41: 273-9.
97. Ghosh S, Papachrysostomou M, Batool M, Eastwood MA. Long-term results of subtotal colectomy and evidence of noncolonic involvement in patients with idiopathic slow-transit constipation. Scand J Gastroenterol 1996; 31: 1083-91.
98. MacDonald A, Baxter JN, Bessent RG, Gray HW, Finlay IG. Gastric emptying in patients with constipation following childbirth and due to idiopathic slow transit. Br J Surg 1997; 84: 1141-3.
99. Vierhout ME, Schreuder HW, Veen HF. Severe slow-transit constipation followed radical hysterectomy. Gynecol Oncol 1993; 51: 401-3.
100. Wexner SD, Cheape JD, Jorge JM, Heymen S, Jagelman DG. Prospective assessment of biofeedback of treatment of paradoxical puborectalis contraction. Dis Colon Rectum 1992; 35: 145-50.
101. Ho Y-H, Tan M, Goh H-S. Clinical and physiological effects of biofeedback in outlet obstruction constipation. Dis Colon Rectum 1996; 39: 520-4.
102. Chiotakaou-Faliakou E, Kamm MA, Roy AJ, Storrie JB, Tumer JC. Biofeedback provides long term benefit for patients with intractable, slow and normal transit constipation. Gut 1998; 42: 517-21.
103. Brown SR, Donati D, Seow-Choen F, Ho Y-H. Biofeedback avoids surgery in patients with slow-transit constipation. Dis Colon Rectum 2001; 44: 737-739.
104. Heyman S, Wexner Sd Vickers D, Nogueras JJ, Weiss EG, Pikarsky AJ. Prospective randomised trial comparing four biofeedback techniques for patients with constipation. Dis Colon Rectum 1999; 42: 1388-93.
105. Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann Intern Med 1994; 121: 520-8.
106. Bleijenberg G, Kuijpers HC. Treatment of spastic pelvic floor syndrome with biofeedback. Dis Colon Rectum 1987; 30: 108-15.
107. Gilliland R, Heymen S, Altomare DF, Park UC, Vickers D, Wexner SD. Outcome and predictors of success of biofeedback for constipation. Br J Surg 1997; 84: 1123-6.
108. Rieger NA, Wattchow DA, Sarri AG et al. Prospective study of biofeedback for treatment of constipation. Dis Colon Rectum 1977; 40: 1143-8.
109. Karlbom U, Hallden M, Eeg-Olofsson KE, Påhlman L, Graf W. Results of biofeedback in constipated patients: a prospective study. Dis Colon Rectum 1997; 40: 1149-55.
110. Emmanuel AV, Kamm MA. Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut 2001; 49: 214-9.